Wednesday, June 25, 2025 | 07:11 PM ISTहिंदी में पढें
Data as at IST. Index data may be delayed by up to 20 minutes. For real-time updates, kindly refer to the BSE and NSE websites.
Cipla Ltd
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
09:34 PM, 20th Feb 2025
Company has received final approval from USFDA for NDA submitted for Nilotinib Capsules 50 150 and 200 mg on 19th February 2025
